Filter by tags: Single-photon emission computed tomography Clear all tag filters
4 news articles found
A Memorandum of Cooperation has been signed between Rosatom and the Kyrgyz Ministry of Health in the field of non-energy use of nuclear technologies in healthcare. The parties agreed to jointly develop high-tech medical projects in Kyrgyzstan. This includes the establishment at the National Centre for Oncology & Haematology of a radiopharmaceutical pharmacy and a centre for molecular visualisation, where advanced methods for diagnosing and treating cancer and other diseases will be used.
- Source: NEI Magazine
- Date: Wednesday, 14 June 2023
- Original article: neimagazine.com/news/newsrosatom-supports-development-of-non-energy-nuclear-technologies-in-kyrgyzstan-10935017
European nuclear trade association Foratom on 14 June released a position paper on, “Medical Uses of Nuclear Technology Role, Challenges & Perspectives”, urging the European Union (EU) to promote new research reactor capacity along with innovation in the sector and the design modification of the current fleet. The 24-page paper, issued jointly with Nuclear Medicine Europe, made a number of recommendations aimed at maintaining the current level of medical radioisotopes supply.
- Source: NEI Magazine
- Date: Friday, 18 June 2021
- Original article: neimagazine.com/news/newsforatom-urges-eu-support-for-nuclear-medicine-8827690
A new radioactive version of the element scandium has been produced in Australia's OPAL reactor for the first time. Scandium-47 has the potential for theranostic use, that is, both as a therapeutic drug and a diagnostic agent, and has similar properties to lutetium-177, which is already being used in clinical trials.
- Source: World Nuclear News
- Date: Friday, 20 March 2020
- Original article: world-nuclear-news.org/Articles/Australia-produces-first-batch-of-medical-isotope
Russian state nuclear corporation Rosatom and Thai engineering and scientific equipment supplier Kinetics Corporation are to supply a cyclotron complex with radiochemical laboratories to the Thailand Institute of Nuclear Technology (TINT) after a turnkey contract was awarded to Kinetics following a tender held by TINT. Rosatom subsidiary Rusatom Healthcare will act as the technology provider. Rosatom said on 7 September that the core of the complex will be a MCC-30/15 cyclotron of 30 MeV proton energy. It will also be used to produce isotopes for PET and SPECT diagnostics. The facility will be located at Ongkharak Nuclear Research Centre in Nakhon Nayok and will accommodate a cyclotron and several laboratories for the production of radiopharmaceuticals for nuclear medicine and other purposes, as well as serve as a platform for R&D activities.
- Source: NEI Magazine
- Date: Wednesday, 13 September 2017
- Original article: neimagazine.com/news/newsrussia-to-supply-cyclotron-complex-to-thailand-5924440